Back | Next |
home / stock / cvac / cvac message board
Subject | By | Source | When |
---|---|---|---|
Interesting new Beneficial Owners recently. Taken an | sdy | investorshub | 07/01/2022 7:06:38 PM |
CureVac NV ($CVAC) | mick | investorshub | 06/06/2022 5:14:21 AM |
CureVac NV ($CVAC) | mick | investorshub | 06/04/2022 6:56:32 PM |
https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-contrafect-cf | mick | investorshub | 04/29/2022 5:44:16 PM |
https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-contrafect-cf | mick | investorshub | 04/29/2022 5:44:15 PM |
CureVac NV ($CVAC) | mick | investorshub | 04/29/2022 5:43:06 PM |
CureVac NV ($CVAC) | mick | investorshub | 03/12/2022 7:34:42 PM |
CureVac NV ($CVAC) | mick | investorshub | 02/05/2022 11:04:06 PM |
https://www.otcmarkets.com/stock/$CVAC | mick | investorshub | 01/02/2022 10:57:48 PM |
https://www.otcmarkets.com/stock/$CVAC | mick | investorshub | 12/11/2021 11:27:32 PM |
CureVac Says Preclinical Trial Shows Antibody Levels of | 2times2 | investorshub | 11/18/2021 8:15:34 PM |
CureVac NV ($CVAC) | mick | investorshub | 11/07/2021 5:55:29 PM |
CureVac NV ($CVAC) | mick | investorshub | 11/05/2021 8:32:21 PM |
GOOD PHARMA STUFF $CVAC | mick | investorshub | 11/05/2021 8:32:10 PM |
took a starter today...have a great weekend | 2times2 | investorshub | 11/05/2021 3:54:30 PM |
CureVac NV ($CVAC) | mick | investorshub | 10/10/2021 4:01:04 PM |
Historic short interest: | XenaLives | investorshub | 09/26/2021 11:56:55 AM |
mRNA-based prophylactic vaccines | XenaLives | investorshub | 09/26/2021 11:51:38 AM |
CureVac Preclinical Data Demonstrates Significant Reduction of Liver | XenaLives | investorshub | 09/26/2021 11:47:05 AM |
CureVac is truly a one-stop shop for mRNA | XenaLives | investorshub | 09/26/2021 11:46:04 AM |
News, Short Squeeze, Breakout and More Instantly...
CureVac N.V. Company Name:
CVAC Stock Symbol:
NASDAQ Market:
Phase 2 study to assess updated formulations for improved immune responses of multivalent vaccine candidate against influenza B strain Study initiated following previously reported interim data from Phase 2 Part of combined Phase 1/2 study in seasonal influenza Composition of vaccine ca...
Organizational redesign on track, trimming residual pandemic infrastructure and reducing 150 positions by year end U.S. FDA Fast Track designation granted for pre-pandemic avian influenza (H5N1) vaccine currently in Phase 1 development; candidate jointly developed with GSK Settlement wi...
Shares of XP Inc. (NASDAQ:XP) fell sharply during Wednesday's session after the company reported worse-than-expected first-quarter EPS results...